Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis.
Erkan TopkanUgur SelekAhmet KucukVeysel HaksoylerYurday OzdemirDuygu SezenHuseyin MertsoyluAli Ayberk BesenYasemin BolukbasiOzgur OzyilkanBerrin PehlivanPublished in: Journal of oncology (2021)
The SIRI ≥ 1.9 independently prognosticated significantly worse OS and PFS results and plated the stage IIIB/C patients into three fundamentally distinct prognostic groups.